BIOSANTE PHARMA INC BPAX (NASDAQ) $ 1.89 Change: -0.11 -5.82% | Volume: 161,354
Sponsored by Click here!

BIOSANTE PHARMA - Fundamental Profile

Company Information

Ticker Symbol: BPAX
Exchange: NASD
Contact Info: 111 Barclay Boulevard Lincolnshire IL 60069 847 478-0500
CEO/President: Stephen M. Simes
Industry: Medical - Biomedical / Standard Industry Code: 2836
Description: Biosante Pharmaceutical is an emerging pharmaceutical company developing a pipeline of hormone therapy products to treat both men and women. BioSante also is developing its nanoparticulate-based platform technology for novel vaccines, vaccine adjuvants and drug delivery systems.

Share Information

Shares Outstanding: 26,800 (000) Market Value: 54,090 ($000)
Percentage of Inst.Shareholders: 10.50% Number of Inst.Shareholders: 29.10%
Last Quarter Sales: 0.02 ($Mil.) Last Quarter Net Income: -6.00 ($Mil.)
Last Quarter EPS: -0.22 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.41
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41